| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 3,947,685 | 13.3% | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | RAPT Therapeutics, Inc. | 2,927,565 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-11 | Kleiner Perkins Caufield & Byers XV, LLC | RAPT Therapeutics, Inc. | 1,259,449 | 4.3% | EDGAR |
| SC 13G | 2022-02-09 | FMR LLC | RAPT Therapeutics, Inc. | 2,248,833 | 7.6% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | RAPT Therapeutics, Inc. | 1,801,469 | 6.1% | EDGAR |
| SC 13D/A | 2021-09-20 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 1,402,008 | 4.8% | EDGAR |
| SC 13D/A | 2021-08-30 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 2,568,674 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 2,585,484 | 10.5% | EDGAR |
| SC 13G/A | 2021-02-16 | Kleiner Perkins Caufield & Byers XV, LLC | RAPT Therapeutics, Inc. | 1,890,599 | 7.7% | EDGAR |
| SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | RAPT Therapeutics, Inc. | 1,577,481 | 6.4% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | RAPT Therapeutics, Inc. | 1,383,981 | 5.6% | EDGAR |
| SC 13G | 2021-02-01 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | RAPT Therapeutics, Inc. | 1,122,237 | 4.5% | EDGAR |
| SC 13G | 2020-12-14 | PERCEPTIVE ADVISORS LLC | RAPT Therapeutics, Inc. | 1,327,481 | 5.4% | EDGAR |
| SC 13G/A | 2020-10-13 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 2,628,020 | 10.7% | EDGAR |
| SC 13D/A | 2020-10-01 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 3,835,679 | 15.7% | EDGAR |
| SC 13D/A | 2020-08-26 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 4,443,679 | 18.2% | EDGAR |
| SC 13G/A | 2020-05-29 | Topspin Fund L.P. | RAPT Therapeutics, Inc. | 559,243 | 2.3% | EDGAR |
| SC 13G | 2020-02-24 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | RAPT Therapeutics, Inc. | 1,342,237,000 | 6.1% | EDGAR |
| SC 13D/A | 2020-02-14 | COLUMN GROUP II, LP | RAPT Therapeutics, Inc. | 4,982,333 | 20.5% | EDGAR |
| SC 13G | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | RAPT Therapeutics, Inc. | 1,183,235 | 5.4% | EDGAR |